OpenEvidence
$170-275kHybrid
San Francisco +2
OpenEvidence
Backed byThrive CapitalAbout OpenEvidence
OpenEvidence is the world’s leading AI medical information platform for health care professionals, launched during the Mayo Clinic Platform Accelerate program. It provides accurate and efficient answers at the point of care, with every answer sourced, cited, and grounded in peer-reviewed medical literature, featuring NEJM content and content from thousands of journals. The platform powers Elsevier’s ClinicalKey AI and was featured by the New England Journal of Medicine AI (NEJM AI). It covers 160 medical specialties, 1,000+ diseases and therapeutic areas, and 1,000,000+ medical topics, and is trusted by medical professionals at 10,000+ care centers across the United States. Investors include Sequoia Capital, Breyer Capital, Mayo Clinic, and Elsevier.
Open positions
Company at a glance
IndustryHealthTech
Team Size11-50
StageSeries D
Founded2021
Locations
San Francisco, United States ·Los Angeles, United States ·New York City, United States
Investors
Alkeon Capital ·Blackstone ·BOND ·Breyer Capital ·Coatue ·Conviction ·Craft Ventures ·DST Global ·Goanna Capital ·Google Ventures ·Greycroft ·ICONIQ Growth ·Kleiner Perkins ·Mayo Clinic ·NVIDIA ·Sequoia Capital ·Thrive Capital
Websiteopenevidence.com
LinkedInLinkedIn
About the Team
Team Distribution
- Other Specialized38%
- Sales & Business Development31%
- Engineering23%
- Operations4%
- Leadership2%
Where the Team Studied
- 1.Stanford University
- 2.Massachusetts Institute of Technology
- 3.Harvard University
- 4.University of Pennsylvania
- 5.University of California, Berkeley
Team Worked At
- Doximity
- Eli Lilly and Company
- Mayo Clinic
- AbbVie
Culture & values
All answers are sourced, cited, and grounded in peer-reviewed medical literature, reflecting a commitment to evidence-based content.
Funding History
Cumulative Funding
Valuation
